All GLP-1 agonists caused reduced fetal growth and decreased weight when used during late gestation and lactation
J Am Coll Cardiol 71(20):22932302 Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, Hilfiker-Kleiner D, Kamiya CA, Mazzarotto F, Cook SA, Halder I, Prasad SK, Pisarcik J, Hanley-Yanez K, Alharethi R, Damp J, Hsich E, Elkayam U, Sheppard R, Kealey A, Alexis J, Ramani G, Safirstein J, Boehmer J, Pauly DF, Wittstein IS, Thohan V, Zucker MJ, Liu P, Gorcsan J 3rd, McNamara DM, Seidman CE, Seidman JG, Arany Z (2016) Shared genetic predisposition in peripartum and dilated cardiomyopathies
Alternatively, if the dosing conditions of oral semaglutide are not suitable, whether it be due to a patient preference to avoid the fasting period or patients receiving other medications with potentially conflicting dosing conditions, then the once-weekly s.c
Broad-Use Case Standouts : Yaoling Biotechnology (Guangzhou) Co., Ltd